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Abstract 
An ever-increasing number of patients have to undergo regular renal dialysis to 
compensate for acute or chronic renal failure. The adequacy of the treatment has a 
profound effect on patients’ morbidity and mortality. Therefore it is necessary to 
assess the delivered dialysis dose. For the quantification of the dialysis dose two 
parameters are most commonly used, namely the Kt/V value (normalised dose of 
dialysis) and the urea reduction rate, yet the prescribed dialysis dose often differs 
from the actual delivered dialysis dose. Currently, no interactive process is available 
to ensure optimal treatment. The aim of this study was to investigate the potential for 
an “electronic nose” as a novel monitoring tool for haemodialysis. Blood samples 
were analysed using an electronic nose, comprising an array of 14 conducting 
polymer sensors, and compared to traditional biochemistry. Principal component 
analysis and hierarchical cluster analysis were applied to evaluate the data, and 
demonstrated the ability to distinguish between pre-dialysis blood from post-dialysis 
blood independent of the method used. It is concluded that the electronic nose is 
capable of discriminating pre-dialysis from post-dialysis blood and hence, together 
with an appropriate classification model, suitable for on-line monitoring.  
 
 
Keywords: electronic nose, conducting polymers, renal failure, kidney disease, 
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1. Introduction 
 
An ever-increasing number of patients have to undergo regular renal dialysis to 
compensate for acute or chronic renal failure. The estimated annual rate of patients 
starting renal replacement therapy (RRT) in England and Wales is 89 per million 
population indicating that approximately 5350 patients started RRT in 2000, 
haemodialysis (HD) being the predominant form of RRT (UK Renal Registry Report, 
2001). The frequency and length of dialysis is generally determined empirically, with 
little or no on-line analysis available to ensure optimal dosage. 
 
1.1 Renal failure and haemodialysis 
Renal failure is characterised by an impaired kidney function leading to 
disturbances in waste excretion, hormone production and in the regulation of fluid and 
electrolyte status. Therefore it is necessary to replace the kidney function by means of 
an artificial device (dialysis) or by organ transplantation. However, artificial devices 
can only replace certain functions of the kidney, in particular the removal of waste 
products and excessive body fluids.  
It is well known that the prescribed dialysis dose differs from the actually delivered 
dialysis dose (Manzoni et al., 1996; Keshaviah, 2002). Therefore, it is necessary to 
quantify the delivered dialysis dose because the adequacy of the dose has a profound 
effect on patient morbidity and mortality (Manzoni et al., 1996; Shak, 1999). The 
concept of dialysis adequacy was developed in the early 1970s to assess the treatment 
efficiency of end-stage renal disease (ESRD) patients (Canaud et al., 2000). From the 
very beginning the removal of small molecules was considered important as they were 
directly linked to the symptoms and signs of uraemia (Keshaviah, 2002; Lindsay and 
Sternby, 2001). Therefore, urea has been suggested as a surrogate marker for small 
toxic solutes (Keshaviah, 2002), and gained wide acceptance in 1975 as a marker 
substance (Vanholder et al., 1994).  
For the quantification of the dialysis dose two parameters are most commonly 
used, namely the urea reduction rate (URR) and the normalised dose of dialysis 
(Kt/V) (Lowrie, 2000; Lindsay and Sternby, 2001). Both parameters are based on 
urea. The URR is calculated from the pre-dialysis and post-dialysis blood urea 
nitrogen value, whereas the Kt/V value is derived from urea kinetic modelling (Levy 
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et al., 2001, Kemp et al., 2001). Devices such as the Baxter Biostat 1000 (Baxter 
Healthcare Corp., McGaw Park, IL), the DQM 200 – Device (Gambro Lund AB, 
Lund, Sweden), the Bio Care Device (Bio-Care Corp., Hsinchu, Taiwan) and the 
Bellco – device (Bellco SpA, Miranda, Italy) are commercially available and calculate 
either of the two parameters on-line. However, there is a controversial discussion 
about whether these parameters are appropriate or not (Vanholder et al., 2002; Lowrie 
2000). However, it has been shown that oversimplification of the “dialysis dose” to 
the Kt/V index might lead to dramatic underdialysis (Canaud et al., 2000). The Kt/V 
value assesses only the removal of small water-soluble compounds from the body 
(Vanholder et al., 2002). Hence, the molecular size of urea means that convective 
and/or diffusive transport of larger molecules is unlikely to be described by urea 
kinetics (Vanholder et al., 2002; Lowrie, 2000).  Both values (Kt/V and URR) assume 
a dialysis frequency of three times per week. However, recently published data 
suggest that 5 % of all American patients skip a dialysis session in any month leading 
to an incorrect Kt/V or URR value (De Palma et al., 2001).  Other pitfalls in 
calculating the Kt/V value come from the incorrect post-dialysis blood sampling such 
as urea-rebound effect, sample dilution with dialysis fluid or blood recirculation. (De 
Palma et al., 2001). However, careful post-dialysis blood sampling minimises the 
influence of these problems (Levy et al. 2001). 
 
1.2 Electronic nose technology 
Electronic nose (EN) is the colloquial name for an instrument made up of chemical 
sensors combined with some sort of pattern recognition system (Gardner and Bartlett, 
1994). The key idea of an EN is to mimic the human olfactory system. The human 
olfactory receptors are replaced by chemical sensors, which produce an electrical 
signal (similar to nerve cells). These signals are subsequently analysed by an 
appropriate pattern recognition engine. The pattern recognition software corresponds 
to the cerebral cortex of the brain, and is able to classify or memorise odours. (Bartlett 
et al., 1997; Pearce, 1997 (a and b)).   
The most commonly used types of sensors in electronic noses are: metal oxide 
sensors (Persaud et al., 1997; Dickinson et al., 1998), conducting polymers (Hatfield 
et al., 1994; Gardner and Bartlett, 1995), and piezoelectric based sensors such as bulk 
acoustic wave sensors or surface acoustic wave sensors (D’Amico et al., 1997; Chang 
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et al., 2000). All types of sensors share a common basic principle. The interaction of 
volatile compounds with the sensor surface leads to a change of physical properties 
(conductivity, resistance, frequency) of the sensor, which is measured. In other words, 
the different types of sensor vary in the way the sensor response is generated.  
Electronic noses have been applied in several areas to characterise the odour of 
products such as beer (Pearce et al., 1993), boartaint (Bourronnet et al., 1995), 
cardboard papers (Holmberg et al., 1995), coffee (Singh et al., 1996), and wine (Di 
Natale et al., 1996; Guadarrama et al., 2001). More recently electronic noses have 
been used for the quality control and process monitoring of foodstuffs such as olive 
oil (Guadarrama et al., 2000; Guadarrama et al., 2001) or milk spoilage (Magan et al, 
2001). However, the ability of ENs as a diagnostic tool is attracting more and more 
research groups. It is well known that smell can be used to diagnose diseases  and has 
been used by both the Greeks and the Chinese since 2,000 BC (Mitruka, 1975). Of 
particular interest are infectious diseases such as bacterial vaginosis (Chandiok et al., 
1997), pulmonary infections (Hanson et al., 1997), tuberculosis (Pavlou and Turner, 
2000), bacteruria (Aathithan et al., 2001) and urinary tract infections (Pavlou et al., 
2002) as well as breath analyses of patients suffering from diabetes (Ping et al., 1997) 
or uraemia (Lin et al., 2001). Di Natale and co-workers (1999) investigated the 
capability of an EN to detect traces of blood in urine samples of kidney patients.  
However, this group could not give an explanation of which volatiles are responsible 
for the sensor response.   
1.3 Aims 
The study was divided into two parts. In the first part, the potential of an electronic 
nose as a novel monitoring system for haemodialysis was investigated. In the second 
part, the electronic nose data were compared to traditional biochemical monitoring 
parameters (urea, creatinine, etc.). The aim of the study was to find out whether there 
was sufficient information within the data to discriminate between pre and post 
dialysis blood.  This was achieved using exploratory data analysis techniques. 
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2. Materials and Methods 
 
2.1 Blood Collection 
 
Blood samples were collected either from patients undergoing intermittent HD-
treatment at Gloucester Royal Hospital or healthy volunteers (Control blood).  Ethical 
approval for this study was obtained from the Gloucestershire Research Ethics 
Committee (Study No.: 01/149G). All patients and volunteers participating in this 
study gave informed written consent before blood samples were taken. Each sample 
was encoded to ensure anonymity.  
All patients are treated either with a Fresenius F6 or Fresenius F8 dialyser 
(Fresenius AG, Bad Homburg v.d.H., Germany) The surface area of the polysulfone 
membrane is either 1.3 m2 (F6 dialyser) or 1.8 m2 (F8 dialyser). The blood flow 
varied between 200 and 350 ml/min, depending on the patient, whereas the dialysate 
flow rate was kept constant at 500 ml/min. All patients included in this study undergo 
haemodialysis treatment three times a week for four hours per session.  
 
2.1.1 Blood collection for biochemical analysis 
From each patient, 10 ml of pre- and post-dialysis blood, respectively and from 
each volunteer 10 ml of control were drawn and placed in Vacuette® Serum tubes 
(Greiner, UK) prior to analysis by the Department of Chemical Pathology at 
Gloucestershire Royal Hospital (Gloucester, UK).  
The relevant details (Gender, Age) are summarised in table 1. 
 
Table 1  
 
2.1.2 Blood collection for the analysis of volatile compounds using an electronic nose 
The analysis of volatile compounds by means of an electronic nose was performed on 
whole blood. Therefore, sampling tubes containing EDTA as an anticoagulant 
(Greiner bio-one, Vacuette®, coagulation tubes) were used for blood sampling. A 
subset (8 control samples, 11 dialysis patient) from the original 11 volunteers and 28 
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patients, respectively were used for this experiment, i.e. the blood samples were taken 
at the same time and from the same patients as for the biochemical analysis.  
. From each patient, 4 ml of pre- and post-dialysis blood, respectively and from 
each volunteer 4 ml of control blood were taken. The blood samples were stored at –
20 ºC until the analysis was performed.  
 
The relevant details (Gender, Age) are summarised in table 2. 
 
Table 2 
 
2.2 Analysis of volatile compounds in blood 
 
2.2.1 Preparation of the blood samples 
Blood samples were defrosted on ice to minimise the loss of volatile compounds.  
Samples were diluted 1:4 in 0.9 % (w/v) NaCl-solution and mixed thoroughly. A 1 ml 
aliquot of the diluted blood was transferred into a 10 ml headspace vial (Jaytee 
Bioscience Ltd., UK) and immediately sealed using a crimp cap with Silicon/Teflon-
septum (Jaytee Bioscience Ltd, UK). The sealed headspace vials were subsequently 
incubated for 45 minutes at 37 ºC.  
 
2.2.2 Gas-sensing system and headspace sampling 
 
For this study an EN (Bloodhound BH-114, Bloodhound Sensors, Leeds, UK) 
employing 14 conducting polymers based on polyaniline was used. The sensor unit 
automatically sets two calibration points. The first one is the baseline, which is 
obtained when activated carbon filtered (Carbon Cap 150, Whatman) air is passed 
over the sensor at a flow rate of 4 ml min-1. The second calibration point is a reference 
point obtained from the headspace of a control sample vial containing 9 ml of RO-
water (Fig. 1).   
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Two sensor parameters were selected in this study: divergence (maximum step 
response) and area (area under the response curve). The sampling profile was set at 10 
s of absorption and 15 s of desorption.  
For the analysis of the unknown headspace, the sample vials were connected to the 
“electronic nose” by inserting a needle into the headspace of the sample vials (Fig. 1). 
The test gaseous phase was passed over the sensor surface at a flow rate of 200 ml 
min-1, which was automatically set by the sensor unit. Between each measurement, a 
time delay of 2 minutes was set. The individual samples were randomly analysed. 
 
Fig. 1 
 
2.3 Data Analysis 
 
To analysis the multivariate data, two standard methods, namely principal 
component analysis (PCA) and hierarchical cluster analysis (HCA) were applied. 
Prior to these methods no scaling was undertaken. To perform these analyses an Excel 
add-in software (XLstat©, version 3.4, France) was used. 
 
2.3.1 Principal Component Analysis  
PCA is an unsupervised data reduction method. The basic idea of the method is to 
describe the variation of a multivariate data set in terms of a set of uncorrelated 
variables, each of which is a particular linear combination of the original variables. In 
other words, the original data matrix is projected from a high dimensional space into a 
less dimensional space, preferably a plane or a 3-dimensional space. During the 
process the original data set is reduced in dimensions, i.e. is compressed, with as little 
loss of information as possible. This is achieved by filtering out the noise in the 
original data matrix, without removing essential information described in the variance 
of the data [Otto, 1999; Massart et al., 1988].  
Mathematically, the key idea of PCA is to decompose the original i x j data matrix 
X into its i x k score matrix T, its k x j loading matrix P and the residual matrix E 
according to: 
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 X = TP + E   (1) 
 
where i is the number of samples, j is the number of variables and k is the number of 
principal components (PCs). The PCs are determined on the basis of the maximum 
variance criterion. Each subsequent PC describes a maximum of variance, which is 
not modelled by the previous one. According to this, the first PC contains the most of 
the variance of the data [Otto, 1999; Everitt and Dunn, 2001]. The relationship 
between samples can be visualised by plotting the scores against each other.  
           
2.3.2 Hierarchical Cluster Analysis  
HCA is an unsupervised method that combines individual samples into clusters 
according to their similarities to each other. The similarity between two samples is 
determined by the (Euclidean) distance between them, which can be calculated for 
two samples p1 (x1, y1) and p2 (x2, y2) as follows: 
  
 d(p1,p2) = [(x1 – x2)2 +(y1-y2)2]1/2   (2) 
 
where d(p1,p2)  is the distance between the two samples.  
The next step is the reduction of the distance matrix by aggregation of clusters, 
whereby the clusters with the shortest distances between them are aggregated first. 
The most commonly used technique, and the one used here, is the Ward’s method. 
The key idea of this method is that clusters are aggregated in such a way, that a 
minimum increase in the within-group variance results [Otto, 1999; Everitt and Dunn, 
2001].  
3. Results 
3.1 Biochemical Analysis 
 
Five biochemical parameters (urea, creatinine, carbon dioxide, phosphate, and 
calcium phosphate) were selected for this analysis and are summarised in table 3. 
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Table 3 
 
As expected, small uremic toxins such as urea and creatinine were effectively 
removed during haemodialysis. However, the post-dialysis concentrations of these 
molecules were higher than compared to healthy subjects. These results are well 
known, but it is almost impossible to present this multivariate data set in a reasonable 
way (two- or three-dimensional space) in their raw form. Therefore, the original 
matrix was reduced in dimensionality using PCA. The results of plotting the PCA 
scores for all samples is shown in Fig 2.  
  
Fig. 2 
 
Fig 2a demonstrates that it is possible to discriminate between post- and pre-
dialysis blood (dashed line) by using the first two PCs (axis 1 and 2), which account 
for 83 % of the variance of the original data matrix. However, it was impossible to 
separate control blood from post-dialysis blood, but according to table 3, there is a 
notable difference. After introducing a third PC (vertical axis 3, Fig. 2b), which 
accounts for 14 % of variance, it was possible to distinguish between control blood 
and post-dialysis blood.    
The HCA revealded similar results to the PCA, as shown in Fig. 3. From the 
original 28-dialysis patients used in this analysis, only in 3 cases (patients: 15, 19, and 
24) was it not possible to distinguish between post- and pre-dialysis blood. This is due 
to small difference between pre – and post-dialysis blood, i.e. there is just a slight 
decrease of the concentrations of the five biochemical parameters during dialysis 
treatment  (data not shown). 
 
Fig. 3  
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3.2 Analysis of volatile compounds in blood using an electronic nose 
 
As can be seen in Fig. 4, a good separation between control blood, pre- and post-
dialysis blood was obtained (dashed lines added by the author). The first two principal 
components (PC) account for 94 % of the variance in the original data matrix. The 
third PC accounts for just 2 % of the variance, and therefore made no significant 
contribution to the discrimination of the samples. 
 
Fig. 4 
 
Similar results were obtained when using HCA, as shown in Fig. 5. In one case 
(patient 9), no difference between pre- and post-dialysis blood was observable. It can 
be seen that the odour of the post-dialysis sample of patient 1 (PoD1) resembled the 
odour of control blood, and the odour of the pre-dialysis sample (PD1) was similar to 
post-dialysis blood.  
 
 
 Fig. 5 
 
 
4. Discussion  
  
This study has shown that by application of multivariate methods combined with 
traditional biochemistry (see 3.1) and modern electronic nose technology (see 3.2), 
respectively, it might be possible to discriminate “uremic” blood from control blood. 
However, more important is the possibility to distinguish between pre- and post-
dialysis blood. It has to be mentioned, that PCA as well as HCA are exploratory data 
analysis techniques, whose main goal to visualise the original data matrix, i.e. they are 
not classification methods. The application of these methods to traditional 
biochemical data (Fig. 2 and 3), demonstrated the efficacy of these tools, even when 
the outcome was not “blinded”.  
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In the second part of the study, an electronic nose was applied to investigate the 
headspace of “uremic” blood and control blood, respectively. The results of this 
experiment were similar to the first one, i.e. a good separation between the different 
types of blood was possible. However, the physical and chemical basis leading to the 
sensor response were more complex. An electronic nose is an array of chemical gas 
sensors, therefore only gas molecules in the sample headspace contribute to the sensor 
response. The volatility of molecules is influenced by many parameters such as 
concentration, equilibration temperature, equilibration time, and viscosity of the 
sample (Seto, 1994).  
To determine which volatiles may be responsible for the difference in electronic 
nose response, it is important to consider the nature of chronic renal failure and its 
treatment. Chronic renal failure is characterised by the accumulation of waste 
products and excessive body fluids. These metabolic waste products as well as body 
fluids are normally excreted with urine. Therefore, “uraemic” blood contains 
numerous compounds, some of them are volatile others are not. In the past, many 
groups tried to identify “uraemic” molecules, which are generally divided into three 
groups: small, middle and large molecules (Levy et al. 2001). Volatile compounds are 
generally small and polar (Gardner and Bartlett, 1999). In the past, several research 
groups identified these molecules using mainly gas chromatography and gas 
chromatography – mass spectroscopy. The range of molecules retained in uraemia is 
broad, including free organic acids, phenolic compounds, aliphatic amines, alcohols, 
aldehydes, ketones and guanidines  (Baba et al., 1984; Liebich et al., 1984; Niwa et 
al., 1981; Liebich et al., 1977). All of them are present in elevated concentrations in 
CRF patients. Bowen et al. (1975) investigated benzyl alcohol present in blood of 
CRF patients. They found elevated values of benzyl alcohol in dialysis patients before 
the session and lower levels after the treatment. Benzyl alcohol was not found in 
normal controls. Baba et al. (1984) analysed serum aliphatic amines using HPLC. 
They found a six-fold increase of methylamine and dimethylamine in uraemic serum 
compared to normal control subjects.  The degree of removal of these compounds is 
smaller than for urea and creatinine and is approximately 55% (Baba et al, 1984; 
Lichtenberger et al., 1993). The same group found similar concentration of the 
volatile ethanolamine in pre-dialysis serum and control serum, but a two-fold 
increased level in post-dialysis samples (Baba et al., 1984).  Other investigators found 
volatiles such as methylmercaptan (Dowty et al., 1975), acetone, 2-butanone, 
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chloroform, benzene, toluene, pyridine, dipropylketone, cycloheaxanone, and 4-
heptanone in uraemic blood (Liebich, 1977). All these substances are characterised by 
a relatively small molecular weight (Mr < 500) and are retained in CRF patients. 
However, due to their low molecular weight they are effectively removed during a 
haemodialysis session, leading to a decreased concentration in post-dialysis samples. 
On the other hand, investigators found an increased oxidative stress in HD patients 
during the treatment mainly caused by the incompatibility of the dialysis membrane. 
This additional oxidative stress leads to the generation of free radicals causing 
enhanced lipid peroxidation (Tetta et al., 1999; Erdogan et al., 2002). The end 
products of lipid peroxidation are aldehydes (malonaldehyde, propanal), ketones 
(acetone) and small carbohydrates (ethane, pentane) (Hageman et al., 1992; 
Capodicasa et al., 1999). This process leads to a continuous increase of volatiles in 
the blood during the treatment.  
From this, we conclude that the sensor response is caused by the combined effect 
of a) removal of accumulated waste products, b) the generation of volatiles during HD 
via lipid peroxidation and c) probably the generation of volatiles during the sample 
incubation period (e.g. ammonia from urea). Therefore, the difference between pre- 
and post-dialysis samples is mainly caused by different concentrations of molecules 
rather than the appearance of new molecules. Hudon et al. (2000) found that 
conducting polymers show a linear relationship between sensor response and 
concentration. This finding is in agreement with Persaud et al. (1996). Our hypothesis 
is supported by the fact, that conducting polymers are very sensitive (5 – 0.1 ppm) 
towards polar molecules (Schiffman et al. 1997).  
In the past only a few applications have been described in the literature where 
electronic noses have been used for renal diseases. Among these is the work of Lin et 
al. (2001), who applied an electronic nose for the diagnosis of uraemia. This group 
found marker substances in the breath of chronic renal failure patients such as di- and 
trimethylamine, which allowed the differentiation between healthy controls and 
uraemic patients. Based on these findings, breath analysis may be a useful substrate 
for a new monitoring system.  
The main aim was to investigate the potential of an electronic nose as a novel on-
line monitoring system for haemodialysis. To date, no medical application could be 
found in the literature where a gas-sensing array was applied on-line and in real-time. 
Such applications described in the literature are mainly located in the food industry or 
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for waste water treatment. For example, Bourgeois et al. (2001) used an electronic 
nose for the on-line monitoring of waste water streams. 
The electronic nose itself showed good reproducibility, i.e. any sensor drift was 
insignificant compared to the difference between samples types.  
 
 
5. Conclusions 
 
This study suggests that electronic nose technology might be a useful tool in 
discriminating pre-dialysis form post-dialysis blood as well as control blood. Together 
with an appropriate classification model, it might be possible to build an on-line 
monitoring system for the management of renal failure. It might also be possible to 
improve and modify currently used sensor arrays towards specific volatile markers or 
marker groups, which would simplify the optimisation of such applications.  
However, more work needs to be done to make this application a rapid and 
efficient diagnostic/monitoring device.  
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Legend: 
 
Table 1: Personal details of volunteers / patients for the biochemical analysis 
 
Table 2: Personal details of volunteers / patients for the analysis of volatile 
compounds using an electronic nose 
 
Table 3: Summary of results of biochemical analysis, showing minimal (min) and 
maximum (max) concentration as well as the mean concentration of Control blood, 
Post- and Pre-dialysis blood 
 
 
Fig. 1: Experimental set-up of the electronic nose. The set-up consists of the 
electronic nose itself, a sample and a control vial as well as two activated carbon 
filters and a HEPA-Vent filter. The carbon filters ensure an odourless airflow over the 
sensor surface and control and sample headspace, whereas the HEPA-VENT filter 
prevents the fouling of the sensor surface. The electronic nose is connected to a PC 
running the control software and a data analysis package.  
 
Fig. 2: PCA – Analysis of Control blood (■), Post-dialysis blood (▲) and Pre-dialysis 
blood (●) based on five biochemical parameters. (a) The first two principal 
components allow the discrimination between pre-dialysis blood and a mixed cluster 
containing post-dialysis blood samples and control blood samples. (b) The 
introduction of a third principal component allows the discrimination between post-
dialysis blood and control blood.  The Post- and Pre-dialysis blood with the same 
number belong to the same patient.  
 
Fig. 3: Cluster analysis of Control blood, Post-dialysis blood and Pre-dialysis blood 
based on five biochemical parameters Legend: PD = Pre-dialysis blood, PoD = Post-
dialysis blood, and C = Control blood 
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Fig. 4: PCA – Analysis of Control blood (■), Post-dialysis blood (▲) and Pre-dialysis 
blood (●) after 45 min incubation at 37 ºC. Post- and Pre-dialysis blood with the same 
number belong to the same patient.  
 
Fig. 5: Cluster Analysis of Control blood, Post- and Pre-dialysis blood after 45 min 
incubation at 37 ºC. Legend: PD = Pre-dialysis blood, PoD = Post-dialysis blood, and 
C = Control blood 
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Table 1 
 
 Volunteers  / Patients Age 
 No. of samples Female Male Mean Median Range 
Control blood 11 6 5 28.3 27 23 - 37 
       
Pre- and Post- 
dialysis blood 
28 7 21 72.3 72.5 51 - 90 
 
 
Table 2 
 
 Volunteers  / Patients Age 
 No. of samples Female Male Mean Median Range 
Control blood 8 5 3 28 26.5 23 - 37 
       
Pre- and Post- 
dialysis blood 11 3 8 72.2 77 51 - 86 
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Table 3 
 
  Control blood Post – dialysis blood 
Pre – dialysis 
blood 
Min 3.61 3.0 9.6 
Max 7.37 16.6 36.1 
Urea 
[mmol L-1] 
Mean 4.87 7.45 21.4 
Min 63.7 183 402 
Max 100.2 659 1194 
Creatinine 
[mmol L-1] 
Mean 77.2 366.5 788.5 
Min 23.12 26.0 20.00 
Max 30.38 35.0 31.00 
CO2 
[mmol L-1] 
Mean 25.76 29.8 25.39 
Min 1.07 0.52 0.79 
Max 1.30 1.65 2.78 
Phosphate 
[mmol L-1] 
Mean 1.16 0.94 1.64 
Min 2.56 1.26 1.90 
Max 3.50 4.31 6.67 Ca
2+ x PO42- 
[mmol L-1] 
Mean 2.90 2.37 4.17 
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Headspace Vial with Aluminium  
PTFE/Silicone Pressure Release Seal 
 
Activated Carbon Filter 
Electronic Nose - 
Bloodhound BH 114 
Control Sample Vial 
Needle 
PC with statistics 
software package 
HEPA-VENTTM - Filter 
Fig. 1  
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